...
Agenda Item | Notes | ||
---|---|---|---|
Quorum evalution (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 18 named members, so 2/3 = 12 (excluding chair and government members) | ||
Open Meeting | |||
Feedback from FDA , specifically Collaborative Community leadership in CDRH on our Charter |
| ||
Feedback from ONC on Roadmap | Was discussed on May 30th call - any follow up? | ||
Logistics of publishing community approved work products | Where do we publish the roadmap - and how to we communicate its publication? <LINK TO FINAL VERSION OF ROADMAP> | ||
Review Working Group Committee list and establish SC representation | Created Confluence pages for the 4 priority groups - announcements on May 30th call Leads will find call time and invite interested people | Does SC want to try to solicit feedback from physicians in time for the proposal deadline? maybe get painpoints from providers and how this relates to SHIELD initatives? | |
NPRM feedback | |||
Call schedule in the summer | June 13th - Andrea will lead - topics:
June 20 - Andrea will lead June 27 - ALL SHIELD call July 4 - need to reschedule - do later in June | ||
Charter updates: Draft non-participation clause for SC | Any volunteers? NOT DISCUSSED | ||
Document decision workflow (e.g. WG product - ALL SHIELD review and comment - comment resolution in WG - Steering Committee approval - work product publication) | NOT DISCUSSED | ||
move to July 11th or just cancel? | |||
Meetings | https://loinc.org/conference/atlanta-2023/ October 17-20 Submit proposals by May 31 Should SHIELD submit something? | ||
Next call | June 20. 2023 12 -1 PM EDT | ||
Adjourned |
For recording access (SC members only) reach out to Riki
Future Agenda Items:
...
Document decision workflow
Logistics of publishing community approved work products
Charter updates: Draft non-participation clause for SC
Prioritization of projects to ensure external milestones are met
qualitative result value set - Standards WG item
guidance on use of sensitivity concepts (as opposed to other results)
in general: have HL7 maintained code system for use in OBX-8 / observation.interpretation in both CDA and FHIR: https://terminology.hl7.org/CodeSystem-v3-ObservationInterpretation.html vs use of OBX-5 / observation.value
for the US specifically
Action items
Quick decisions not requiring context or tracking
...